Prognostic value of glim criteria in patients with BCLC stage B or C hepatocellular carcinoma who underwent systemic therapy
This study validated the prognostic value of GLIM criteria in patients with the Barcelona Clinic Liver Cancer (BCLC) stage B or C hepatocellular carcinoma (HCC) who underwent systemic treatment.
Source: Clinical Nutrition ESPEN - Category: Nutrition Authors: D. Chen, N. Tang, J. Pan, H. Ren, S. Wang, H. Ma, Z. Wang, G. Zhang, Y. Cao, Y. Lu, W. Ge, C. Jiang, X. Wu, X. Zhu Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Liver | Liver Cancer | Nutrition | Study | Urology & Nephrology